Table 3. Comparison of association between immunohistochemical expression of vimentin and α-SMA in benign breast and paired cases of primary invasive breast cancer or metastasis to axillary lymph node.
|
Vimentin-positive fibroblast
|
||||
|---|---|---|---|---|
| α-SMA-positive fibroblast | Negative | Heterogeneous | Homogeneous | Association of expression (%)a |
| Benign breast | 0 | |||
| Negative | 0 | 0 | 11 | |
| Heterogeneous | 0 | 0 | 0 | |
| Homogeneous | 0 | 0 | 0 | |
| Primary breast cancer | 95 | |||
| Negative | 0 | 0 | 2 | |
| Heterogeneous | 0 | 0 | 6 | |
| Homogeneous | 0 | 0 | 31 | |
| Breast cancer metastasis to LN | 92 | |||
| Negative | 0 | 1 | 2 | |
| Heterogeneous | 0 | 0 | 1 | |
| Homogeneous | 0 | 0 | 35 | |
Abbreviation: α-SMA=α-smooth muscle actin.
Association between the expression of vimentin and α-SMA in benign breast and paired cases of primary invasive breast cancer or metastasis to lymph nod.